Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
14
×
Tags
boston
14
×
boston blog main
life sciences
14
×
national blog main
boston top stories
biotech
clinical trials
startups
new york blog main
deals
national top stories
new york top stories
fda
investing
venture capital
drugs
financing
medical device
funding
perceptive advisors
san francisco blog main
san francisco top stories
sanofi
series a
third rock ventures
20/20 healthcare partners
480 biomedical
abbott laboratories
abbvie
accelerated approval
access biotechnology
access industries
acute hepatic porphyria
adel malek
akero therapeutics
aldehyde
aldeyra therapeutics
allergic conjunctivitis
allopregnanolone
allosteric
What
new
14
×
medicines
medicine
drug
therapeutics
biotech
drugs
ipo
million
raised
address
aims
approach
based
bio
body
called
cells
companies
company
data
develop
developing
device
disease
diseases
fda
genetic
lead
molecules
multiple
neuro
raises
research
rna
second
step
studies
tests
absorb
Language
unset
Current search:
new
×
photo
×
" life sciences "
×
boston
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines